Professional Documents
Culture Documents
Oligodendrogliomas are intracranial tumours that account for 5-25% of all gliomas and 5-10% of all primary
intracranial neoplasms. They are identified on histological grounds and by 1p19q codeletion.
On imaging these tumour commonly present as a round or oval sharply marginated mass involving the cortex
or subcortical white matter, with low attenuation on CT, hypointense compared to gray matter on T1 and
hyperintense compared to gray matter on T2-weighted MRI images. The attenuation or signal can be
eventually heterogeneous due to calcification, cystic degeneration and hemorrhage.
Epidemiology
These are usually tumours of middle-aged adults, occurring most commonly in the 4 th and 5th decades of life.
Oligodendroglioma is considered the third most common glioma accounting for 2%5% of primary brain tumors
and 5%18% of all glial neoplasms 8.
Clinical presentation
Due to their usual cortical involvement, presentation is most frequently as a result of seizures.
Pathology
Gross appearance
Generally, oligodendrogliomas are well-circumscribed, gelatinous, gray masses. They are usually calcified (7090%: one of the most frequently calcifying tumours), less often with focal haemorrhage. 20% of these tumours
are cystic, and they can often expand a gyrus and remodel the skull. They can occur essentially anywhere,
including intraventricularly where they are difficult to distinguish from central neurocytomas on light microscopy.
Oligoastrocytoma
Oligoastrocytomas, a tumour of mixed oligodendroglioma and astrocytoma cell populations have historically
been variably reported depending on local practice. As of the 2016 update to the WHO classification of CNS
tumours, to make the diagnosis genomic evidence of both astrocytic and oligodendroglial components will be
required to make the diagnosis, and as such they are likely to become rare.
2,7
Radiographic features
CT
Non contrast CT
Tumours are of mixed density (hypodense to isodense). High-attenuation areas within the tumour are likely
from calcification (70-90% of oligodendrogliomas are calcified) or, less commonly, haemorrhage. Calcification
can be located centrally, peripherally or they can be ribbon-like 4. The overlying skull may show pressure
erosion.
Post contrast CT
50% of oligodendrogliomas enhance: degree of enhancement is extremely variable (no enhancement to
striking).
MRI
Tumours in which 1p/19q is intact show more homogenous signal on T1 and T2 images and have sharper
borders than tumours with 1p/19q deletions. Calcification and haemorrhage are difficult to distinguish on MR.
Peritumoral vasogenic oedema is minimal.
T1 C+ (Gd): contrast enhancement is common but it is not a reliable indicator of tumour grade, with
only 50% of oligodendrogliomas enhancing to a variable degree, and usually heterogeneously
DWI
o
DWI can be used to help differentiate oligodendrogliomas (generally lower grade) from
astrocytomas (generally higher grade); astrocytomas have higher ADC values probably because of their
higher cellularity 5
MR perfusion: increased vascularity "chicken wire" network of vascularity results in elevated relative
cerebral blood volume (rCBV) of grade II vs grade III on PWI; PWI has a sensitivity of 95% and PPV or 87%
for distinguishing grade II from grade III oligodendrogliomas 1; a threshold of 1.75, rCBV above this
threshold demonstrate more rapid tumour progression 1
PET
C-Methionine studies can be used to differentiate oligodendrogliomas from anaplastic oligodendrogliomas.
FDG uptake of oligodendrogliomas is similar to normal white matter. FDG uptake of anaplastic
oligodendrogliomas is similar to normal gray matter.
11
Differential diagnosis
General imaging differential considerations include:
astrocytoma
ganglioglioma
cerebral ischaemia/infarction
References
Edit Article Share
Article Information
Case 2: typical CT
Case 3: anaplastic
Case 4: anaplastic
Case 5: MRS
Case 6: perfusion
Case 7
Case 8
Case 9
Case 11
Case 10
Case 12
Case 13
Case 14
Case 15
Case 16
DNET
Gangliogioma